Comparison of antimicrobial efficacy of a fixed dose combination of ceftazidime + sulbactam with ceftazidime and sulbactam alone against five bacteria
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu srovnávací studie, časopisecké články
- MeSH
- antibakteriální látky farmakologie MeSH
- Bacteria účinky léků MeSH
- ceftazidim farmakologie MeSH
- mikrobiální testy citlivosti MeSH
- sulbaktam farmakologie MeSH
- Publikační typ
- časopisecké články MeSH
- srovnávací studie MeSH
- Názvy látek
- antibakteriální látky MeSH
- ceftazidim MeSH
- sulbaktam MeSH
The efficacy of the agents was evaluated on the basis of minimum inhibitory concentration (MIC) and time-kill curve analysis in Pseudomonas aeruginosa, Staphylococcus aureus, Acinetobacter baumannii, Mycobacterium smegmatis, and Citrobacter braakii; MIC was found to be 0.5, 4.0, 0.015625, 0.0078125, and 0.0625 mg/L in FDC of ceftazidime + sulbactam, respectively, which is lower than ceftazidime and sulbactam individually. Time-kill curve analysis demonstrated maximum killing of bacteria after 4 h. A fixed dose combination of ceftazidime + sulbactam was found to have stronger antibacterial properties than ceftazidime and sulbactam alone at in vitro analysis.
Zobrazit více v PubMed
J Antimicrob Chemother. 1985 Mar;15(3):305-10 PubMed
J Antimicrob Chemother. 1983 Jul;12 Suppl A:213-7 PubMed
J Antimicrob Chemother. 1981 Jul;8 Suppl A:121-32 PubMed
Clin Infect Dis. 1997 Sep;25(3):551-73 PubMed
Antimicrob Agents Chemother. 1982 Jun;21(6):939-43 PubMed
Antimicrob Agents Chemother. 1985 Apr;27(4):515-9 PubMed
Int J Antimicrob Agents. 2001 Feb;17(2):143-6 PubMed
Clin Infect Dis. 2000 Aug;31(2):347-82 PubMed
Chemotherapy. 1984;30(1):31-4 PubMed
Antimicrob Agents Chemother. 1984 Jun;25(6):725-8 PubMed
Clin Infect Dis. 1998 Mar;26(3):576-83 PubMed
J Antimicrob Chemother. 1983 Jul;12 Suppl A:93-9 PubMed
Rev Infect Dis. 1982 Mar-Apr;4(2):294-301 PubMed
Folia Microbiol (Praha). 2008;53(1):57-60 PubMed
Antimicrob Agents Chemother. 1985 Feb;27(2):207-16 PubMed
Clin Pharm. 1984 Jul-Aug;3(4):373-85 PubMed
Clin Microbiol Rev. 2001 Oct;14(4):933-51, table of contents PubMed
Clin Infect Dis. 1993 Aug;17(2):295-6 PubMed
Infection. 1980;Suppl 1:45-8 PubMed
Am J Clin Pathol. 1985 Oct;84(4):496-504 PubMed
Antimicrob Agents Chemother. 1985 Jul;28(1):33-6 PubMed
Antimicrob Agents Chemother. 1981 Mar;19(3):407-13 PubMed
Arch Dis Child. 1985 Apr;60(4):360-4 PubMed
Eur J Clin Microbiol Infect Dis. 1996 Aug;15(8):625-34 PubMed